ADmit Therapeutics
ID: 13186771ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.
2
Funding Rounds
$456.2k
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company ADmit Therapeutics has raised a total of $456.22k in funding over 2 rounds.
Key Insights:
- ADmit Therapeutics Seed round, March 27, 2019: $226.22k
- ADmit Therapeutics March 2019 Pre-Seed Funding Round: $230k
Industries
ADmit Therapeutics is active in the following industries: